Stocks Closed Up, S&P And Nasdaq Make Another New All-Time High, CPI Inflation Report On Tap This Morning

Market Moves You Need to See Stocks Closed Up, S&P And Nasdaq Make Another New All-Time High, CPI Inflation Report On Tap This Morning [Kevin Matras - EVP - Photo] Profit from the Pros By Kevin Matras Executive Vice President Stocks Closed Up, S&P And Nasdaq Make Another New All-Time High, CPI Inflation Report On Tap This Morning Stocks closed solidly higher yesterday with all of the major indexes up 1% or better. And once again, the S&P and Nasdaq each made another new all-time high. Yesterday, Fed Chair Jerome Powell, in day 2 of his Semiannual Monetary Policy testimony, this time to the U.S. House Financial Services Committee (on day 1 he spoke to the U.S. Senate Committee on Banking, Housing, and Urban Affairs), essentially repeated what he said the day before: that there's been considerable progress on inflation, that the economy is doing well, and that the job market, is strong but not overheated. And he reiterated that the Fed remains data dependent, and that they'd like to see more good inflation reports in order to have a greater degree of confidence that inflation is on a sustainable path back to 2% before cutting interest rates. He also cited the Fed's dual mandate of price stability (moderate inflation) and to promote maximum employment. He acknowledged that these two items are more balanced now than they were previously, but that they're watching for signs of slowing, saying that "reducing policy restraint too late or too little could unduly weaken economic activity and employment." While no timeline was given on when the Fed will cut rates, they recently forecast 1 rate cut by year's end, with Fed Funds traders putting odds on September at the earliest, but more likely November or December. His comments were interpreted bullishly, just like the day before. But given the Fed's data dependence, all eyes will be on this morning's Consumer Price Index (CPI) inflation report. Last month's core rate (ex-food & energy) came in at 3.4% annually, down from the previous month's 3.6%, and well below their peak from 2 years ago at 6.6%. Today's consensus is for the headline number to be up 0.1% m/m vs. last month's 0.0%, with the y/y rate at 3.1%, down from last month's 3.3%. The core rate is expected to be up 0.2% m/m, just like the previous month, while the y/y rate is expected to be up 3.5% vs. last month's 3.4%. That comes out at 8:30 AM ET. We'll then get another look at inflation tomorrow with the Producer Price Index (PPI) inflation report. But first things first. Today it's the CPI. And we'll also get Weekly Jobless Claims. Should be a busy day. See you tomorrow, [Kevin Matras - Signature] Kevin Matras Executive Vice President, Zacks Investment Research Sponsor [FREE Email Alerts: Fresh AbleTrend Signals for Up-trend Stocks at Dip]( Identify up-trend stocks at their launch points with AbleTrend's award-winning signals. These stocks have already established an uptrend and have pulled back to AbleTrend support levels, presenting a prime buying opportunity with reduced risk. [Sign up now]( to receive real-time email alerts for fresh AbleTrend signals as they appear. Stay informed about uptrend stocks at their dips and view these signals in progress. With AbleTrend, trading becomes more informed and decisive. Buy on blue and sell on red. No more guessing, no more stress. Follow AbleTrend's path, invest with confidence, and let go of the rest [Sign up now]( Today's Top Research [Arm Holdings (ARM) Hits 52-Week High: What's Next for Investors?]( This year, ARM shares have seen an impressive rise of 156%, significantly outpacing the industry's 22% rally. [Read More »]( [Earnings Season Gets Underway: Bank Earnings in Focus]( The earnings outlook for the major banks has been improving lately as underlying business trends have stabilized. [Read More »]( [Celestica (CLS) Surges 274% in a Year: Should You Ride the Wave?]( Operating primarily as a behind-the-scenes partner for other electronics businesses, Celestica is among the lesser-known winners of the AI revolution. [Read More »]( [Top Medical Stocks to Buy for Growth & Performance]( Considering their impressive decade performances and continued expansion, HALO, NBIX, and HAE are three highly-ranked medical stocks that should be at the forefront of investor attention. [Read More »]( [Silver or Gold: Which ETFs Should You Buy for 2H 2024?]( Silver and gold are again grabbing investor attention following bouts of softer U.S. data. [Read More »]( [Advance Notice to Zacks Members]( [Earnings Surprises] Imagine being able to KNOW which stocks will beat expectations this earnings season. You’d be able to buy early and take profits on the climbing prices. Zacks proprietary "ESP" formula has given members exactly that chance. Since 2014, it has predicted positive earnings surprises with incredible 80% accuracy! Now, it’s locked onto an elite handful of stocks set to stun Wall Street when their earnings reports are released. You can be among the first to get in on these picks BEFORE other investors rush in and drive up the prices. Don't delay: Access is closing to new investors. [See Surprise Stocks Now »]( [Bull of the Day: ASML Holding (ASML)]( ASML enjoys a competitive advantage in its industry, which has led to tremendous sales, earnings and stock price growth over the last decade. [Read More »]( [New Zacks Strong Buys for July 11th]( Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. [Read More »]( More Zacks Resources Mobile App Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com. [Download our Zacks App for Apple iOS]( [Download our Zacks App for Android]( Zacks Members' Success Stories Visit [Success Stories]( to hear how Zacks research, tools and portfolios help our members outperform the market. Get all of our market insights and much more when you connect with us. [Visit Zacks on Facebook]( [Follow Zacks on Twitter]( [See Zacks videos on YouTube]( [Join Zacks on LinkedIn]( [Read Zacks Commentary on StockTwits]( This free resource is being sent by [Zacks.com](. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service". [www.zacks.com/terms_of_service]( Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment adviser or investment bank. The Zacks #1 Rank Performance covers the period beginning on January 1, 1988 through June 3, 2024. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank #1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit [( for information about the performance numbers displayed above. Zacks Emails If you would prefer to not receive future profit-producing emails from [Zacks.com]( the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please [click here]( and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com. Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606